Data gathered: July 26
Alternative Data for Iovance Biotherapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 60 | Sign up | Sign up | Sign up |
| Sentiment | 97 | Sign up | Sign up | Sign up |
| Webpage traffic | 30,000 | Sign up | Sign up | Sign up |
| Employee Rating | 67 | Sign up | Sign up | Sign up |
| Google Trends | 10 | Sign up | Sign up | Sign up |
| Patents | 191 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 51 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,701 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,339 | Sign up | Sign up | Sign up |
| Twitter Mentions | 33 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 68 | Sign up | Sign up | Sign up |
| Linkedin Employees | 620 | Sign up | Sign up | Sign up |
About Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
| Price | $9.25 |
| Target Price | Sign up |
| Volume | 6,520,000 |
| Market Cap | $2.64B |
| Year Range | $5.05 - $17.47 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
 |
Comparing Iovance Biotherapeutics (NASDAQ:IOVA) & Halozyme Therapeutics (NASDAQ:HALO)July 25 - ETF Daily News |
Iovance Biotherapeutics put volume heavy and directionally bearishJuly 24 - Thefly.com |
|
Interesting IOVA Put And Call Options For September 6thJuly 24 - Stock Options Channel |
|
 |
Brokers Issue Forecasts for Iovance Biotherapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:IOVA)July 21 - ETF Daily News |
How Is The Market Feeling About Iovance Biotherapeutics?July 21 - Benzinga |
|
Interesting IOVA Put And Call Options For March 2025July 21 - Stock Options Channel |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 810,000 | 7.3M | -6.5M | -113M | -113M | -0.420 |
| Q4 '23 | 590,000 | 4.4M | -3.8M | -116M | -117M | -0.450 |
| Q3 '23 | 470,000 | 4.3M | -3.9M | -114M | -114M | -0.460 |
| Q2 '23 | 240,000 | 2.1M | -1.8M | -107M | -108M | -0.470 |
| Q1 '23 | 180,000 | 0 | -28M | -107M | -111M | -0.500 |
Insider Transactions View All
| Dukes Iain D. filed to buy 54,000 shares at $9.2. February 20 '24 |
| MCPEAK MERRILL A filed to buy 320,150 shares at $9.2. February 20 '24 |
| Rothbaum Wayne P. filed to buy 28,067,333 shares at $9.2. February 20 '24 |
| MCPEAK MERRILL A filed to buy 248,633 shares at $5.6. September 19 '23 |
| Rothbaum Wayne P. filed to buy 23,067,333 shares at $5.3. September 15 '23 |
Similar companies
Read more about Iovance Biotherapeutics (IOVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Iovance Biotherapeutics?
The Market Cap of Iovance Biotherapeutics is $2.64B.
What is the current stock price of Iovance Biotherapeutics?
Currently, the price of one share of Iovance Biotherapeutics stock is $9.25.
How can I analyze the IOVA stock price chart for investment decisions?
The IOVA stock price chart above provides a comprehensive visual representation of Iovance Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Iovance Biotherapeutics shares. Our platform offers an up-to-date IOVA stock price chart, along with technical data analysis and alternative data insights.
Does IOVA offer dividends to its shareholders?
As of our latest update, Iovance Biotherapeutics (IOVA) does not offer dividends to its shareholders. Investors interested in Iovance Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Iovance Biotherapeutics?
Some of the similar stocks of Iovance Biotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.